ADMA Biologics Inc Common Stock

ADMA US0008991046

💰
Capitalization
Mid-cap

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Annual Performance 1
2021 2022 2023 2024 2025
-33% 164% 17% 277% 3%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
42
🙍
Insiders
7
Person Price Shares Total Published Completed
Grossman Adam S
CEO
16.13
USD
15,000
Sold
241,950
USD
15/09/2025 15/09/2025
Grossman Adam S
CEO
16.13
USD
6,000
Sold
96,780
USD
15/09/2025 15/09/2025
Grossman Adam S
CEO
16.88
USD
15,000
Sold
253,200
USD
15/08/2025 15/08/2025
Grossman Adam S
CEO
16.88
USD
6,000
Sold
101,280
USD
15/08/2025 15/08/2025
Grossman Adam S
CEO
18.66
USD
6,000
Sold
111,960
USD
15/07/2025 15/07/2025
Grossman Adam S
CEO
18.66
USD
15,000
Sold
279,900
USD
15/07/2025 15/07/2025
Elms Steve
20.24
USD
194,749
Sold
3,941,720
USD
12/06/2025 16/06/2025
Grossman Adam S
CEO
20.81
USD
15,000
Sold
312,150
USD
16/06/2025 16/06/2025
Grossman Adam S
CEO
20.81
USD
6,000
Sold
124,860
USD
16/06/2025 16/06/2025
Elms Steve
20.82
USD
137,931
Sold
2,871,723
USD
12/06/2025 13/06/2025

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include ADMA Biologics Inc Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
11% 34% 196% 362% 511% 505% 134%
Last 52W Low 52W High All-Time Low All-Time High β
13.99 13.99 24.51 13.99 24.51
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Elms Steve 8 17,972,492.54 2,246,561.57 13/03/2024 16/06/2025
Grossman Adam S 20 16,216,130.96 810,806.55 14/06/2024 15/09/2025
Grossman Jerrold B 4 3,003,231.62 750,807.91 29/08/2024 09/06/2025
Guiheen Lawrence P. 7 1,369,860.20 195,694.31 09/09/2024 09/06/2025
Kwon Young 1 1,095,600.00 1,095,600.00 23/08/2024 23/08/2024
Kestenberg-messina Kaitlin M. 1 408,050.47 408,050.47 30/08/2024 30/08/2024
Tade Brad L. 1 317,250.00 317,250.00 22/11/2024 22/11/2024

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Connected Companies 3
Name ISIN Ticker
Tapimmune Inc. US57055L2060 MRKR

3 the firms where the current insiders have executed transactions.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.